CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $710,000 | -18.6% | 11,322 | -1.6% | 0.22% | -17.3% |
| Q4 2021 | $872,000 | -32.3% | 11,511 | 0.0% | 0.27% | -41.3% |
| Q3 2021 | $1,288,000 | -30.4% | 11,511 | +0.7% | 0.46% | -30.4% |
| Q2 2021 | $1,850,000 | +36.7% | 11,428 | +2.9% | 0.66% | +23.8% |
| Q1 2021 | $1,353,000 | -20.9% | 11,107 | -0.6% | 0.54% | -24.6% |
| Q4 2020 | $1,711,000 | +87.0% | 11,173 | +2.2% | 0.71% | +65.6% |
| Q3 2020 | $915,000 | +15.8% | 10,931 | +1.6% | 0.43% | +1.2% |
| Q2 2020 | $790,000 | +73.2% | 10,759 | 0.0% | 0.42% | +34.1% |
| Q1 2020 | $456,000 | -24.8% | 10,759 | +8.1% | 0.32% | -12.7% |
| Q4 2019 | $606,000 | +43.6% | 9,954 | -3.2% | 0.36% | +40.2% |
| Q3 2019 | $422,000 | – | 10,283 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |